Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
Journal for Immunotherapy of Cancer
|
January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Cancers
|
June 28, 2023
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
Ritaparna Ahmed, Leyder Elena Lozano, Amandine Anastasio, et al.
Cytotherapy
|
October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment
Philippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Nature Communications
|
September 29, 2025
Neuron-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells display an encephalitogenic transcriptional program in autoimmune encephalitis
Sylvain Perriot, Samuel Jones, Raphaël Genolet, et al.
The Journal of Experimental Medicine
|
January 16, 2008
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari, Pierre-Alexandre Bart, Wolfgang Stöhr, et al.
Plos One
|
April 27, 2012
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
Carmen Elena Gómez, Beatriz Perdiguero, Victoria Jiménez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
George Coukos, Marco Donia, Brian R Gastman, et al.
Nature Biotechnology
|
November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
Marion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Science Advances
|
June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer
Margaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Nature Communications
|
March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancer
Sara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
Journal for Immunotherapy of Cancer
|
January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Cancers
|
June 28, 2023
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
Ritaparna Ahmed, Leyder Elena Lozano, Amandine Anastasio, et al.
Cytotherapy
|
October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment
Philippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Nature Communications
|
September 29, 2025
Neuron-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells display an encephalitogenic transcriptional program in autoimmune encephalitis
Sylvain Perriot, Samuel Jones, Raphaël Genolet, et al.
The Journal of Experimental Medicine
|
January 16, 2008
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari, Pierre-Alexandre Bart, Wolfgang Stöhr, et al.
Plos One
|
April 27, 2012
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
Carmen Elena Gómez, Beatriz Perdiguero, Victoria Jiménez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
George Coukos, Marco Donia, Brian R Gastman, et al.
Nature Biotechnology
|
November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
Marion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Science Advances
|
June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer
Margaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Nature Communications
|
March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancer
Sara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Page
of 13